momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (10884)	8/4/2016 3:01:44 PM
From: tuck	Read Replies (1) of 12215

Swing traded my ADAP position, selling out in the low $8s a few days ago. Today they announce a partial clinical hold on the MRCLS trial, which hasn't begun recruiting. No other trials affected, and it appears to be CMC and design concerns from the FDA. Says they'll talk about it on their upcoming earnings call (8/8). One writer just speculated it had to with the company's ability to supply the correct dose at all sites, and that the issue can be resolved in a month or so. The pullback seems very muted, as if the market buys this theory. It's still 5% above where I sold it, having had a nice pop in the last couple of weeks. I'm not sure what to make of that theory. Why wouldn't it be a concern with the other trials? Because most of them are recruiting and they're doing OK on that metric? So why worry about that metric on this trial? Watching, not buying this eensy pullback. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next